Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Central Coast Health Watch  -  Page 73

Dignity Health
Latest

Oak Therapeutics touts study results for dissolvable strips

By   /  Thursday, October 5th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Oak Therapeutics touts study results for dissolvable strips

Oak Therapeutics, based in Oxnard, announced that it completed a study of the use of its dissolvable strips to administer an anti-tuberculosis treatment orally. A 300 milligram dose of isoniazid on the dissolvable strips given to canines entered the bloodstream at a statistically similar rate to commercial tablets, the study found. The company, a subsidiary Read More →

Read More →
Latest

Amgen lawsuit over cholesterol drug will get new trial

By   /  Thursday, October 5th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen lawsuit over cholesterol drug will get new trial

An Amgen lawsuit against a competing cholesterol drug will get a new trial but sales of the drug will be allowed in the U.S. until a decision is rendered. A federal court of appeals judge threw out a ban on the sale of Praluent, manufactured by New York-based Regeneron Pharmaceuticals and French biotech company Sanofi Read More →

Read More →
Latest

Mannkind stock soars over new label info for Afrezza

By   /  Monday, October 2nd, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Mannkind stock soars over new label info for Afrezza

Westlake Village biotech company Mannkind received approval to update the prescribing information for its inhalable insulin product, Afrezza, making it easier to market to customers. The new label information clarifies starting and adjusting mealtime dosages, as well as initial and peak effects, and helps the company avoid confusing language, CEO Michael Castagna said in a Read More →

Read More →
Latest

Amgen settles with AbbVie over Humira biosimilar

By   /  Thursday, September 28th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen settles with AbbVie over Humira biosimilar

Thousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →

Read More →
Latest

Amgen agrees to develop biosimilars for Chinese market

By   /  Tuesday, September 26th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen agrees to develop biosimilars for Chinese market

Increasing its global footprint in the biosimilars market, Amgen announced Sept. 26 that it had formed an exclusive co-development agreement with Chinese drug manufacturer Simcere Pharmaceutical Group. The agreement aims to bring four oncology and inflammation biosimilars in Amgen’s portfolio to commercialization in China. The Thousand Oaks-based biotechnology company will produce and submit approval applications Read More →

Read More →
Latest

Amgen reaffirms earnings outlook after hurricane hits Puerto Rico

By   /  Monday, September 25th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen reaffirms earnings outlook after hurricane hits Puerto Rico

After reviewing the impacts to its Puerto Rico manufacturing facility from Hurricane Maria, Thousand Oaks biotech giant Amgen reaffirmed its earnings outlook Sept. 25 and said that outreach to impacted staff was ongoing. The storm did not damage any product or in-process inventory at the plant, and the company said it did not expect any Read More →

Read More →
Latest

Tri-county biotech companies targeting quality of life

By   /  Friday, September 22nd, 2017  /  Central Coast Health Watch, Education, Latest news, Technology  /  Comments Off on Tri-county biotech companies targeting quality of life

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →